NECLIFE

Nectar Lifesciences Share Price Nectar Lifesciences

₹32.6
-1.25 (-3.69%)
16 April, 2024 00:40 BSE: 532649 NSE: NECLIFEISIN: INE023H01027

Start SIP in Nectar Lifesciences

Start SIP

Nectar Lifesciences Performance

Day Range

  • Low 32
  • High 34
₹ 32

52 Week Range

  • Low 17
  • High 46
₹ 32
  • Open Price34
  • Previous Close34
  • Volume333537

Nectar Lifesciences Share Price

  • Over 1 Month 6.02%
  • Over 3 Month -4.96%
  • Over 6 Month 31.19%
  • Over 1 Year 85.75%

Nectar Lifesciences Key Statistics

P/E Ratio 90.5
PEG Ratio 0.6
Market Cap Cr 731
Price to Book Ratio 0.7
EPS -2.8
Dividend 0
Relative Strength Index 43.8
Money Flow Index 47.61
MACD Signal -0.34
Average True Range 1.96
Nectar Lifesciences Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 452398394389
Operating Expenses Qtr Cr 410371359369
Operating Profit Qtr Cr 42273620
Depreciation Qtr Cr 15151515
Interest Qtr Cr 25211820
Tax Qtr Cr 111-2
Net Profit Qtr Cr 2125
IndicatorMar 2023
Total Revenue Annual Cr 1,567
Operating Expenses Annual Cr 1,469
Operating Profit Annual in Cr 55
Depreciation Cr 59
Interest Annual Cr 79
Tax Annual Cr -18
Net Profit Annual Cr -22
IndicatorMar 2023
Cash from Operating Activity Annual Cr 133
Cash from Investing Activity Annual Cr 52
Cash from Financing Annual Activity Cr -186
Net Cash Flow Annual Cr 0
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 1,065
Fixed Assets Annual Cr 740
Total Non Current Assets Annual Cr 772
Total Current Assets Annual Cr 1,417
Total Assets Annual Cr 2,189
IndicatorMar 2023
Book Value Per Share Annual Rs 47
ROE Annual % -2
ROCE Annual % 3
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 6
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 452398394389
Operating Expenses Qtr Cr 410371359371
Operating Profit Qtr Cr 42273618
Depreciation Qtr Cr 15151515
Interest Qtr Cr 25211820
Tax Qtr Cr 111-2
Net Profit Qtr Cr 2124
IndicatorMar 2023
Total Revenue Annual Cr 1,567
Operating Expenses Annual Cr 1,471
Operating Profit Annual in Cr 53
Depreciation Cr 59
Interest Annual Cr 79
Tax Annual Cr -18
Net Profit Annual Cr -24
IndicatorMar 2023
Cash from Operating Activity Annual Cr 134
Cash from Investing Activity Annual Cr 52
Cash from Financing Annual Activity Cr -186
Net Cash Flow Annual Cr 0
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 1,065
Fixed Assets Annual Cr 740
Total Non Current Assets Annual Cr 772
Total Current Assets Annual Cr 1,417
Total Assets Annual Cr 2,189
IndicatorMar 2023
Book Value Per Share Annual Rs 47
ROE Annual % -2
ROCE Annual % 3
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 6

Nectar Lifesciences Technicals

EMA & SMA

Current Price
₹32.6
-1.25 (-3.69%)
pointer
  • Bullish Moving Average
  • ___
  • 3
  • Bearish Moving Average
  • ___
  • 13
  • 20 Day
  • ₹33.99
  • 50 Day
  • ₹34.31
  • 100 Day
  • ₹33.01
  • 200 Day
  • ₹30.01
  • 20 Day
  • ₹32.94
  • 50 Day
  • ₹35.70
  • 100 Day
  • ₹33.90
  • 200 Day
  • ₹29.00

Nectar Lifesciences Resistance and Support

PIVOT
₹32.69
Resistance
First Resistance 33.42
Second Resistance 34.23
Third Resistance 34.97
RSI 43.80
MFI 47.61
MACD Single Line -0.34
MACD -0.14
Support
First Resistance 31.87
Second Resistance 31.13
Third Resistance 30.32

Nectar Lifesciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 371,078 18,694,910 50.38
Week 292,029 16,706,950 57.21
1 Month 651,232 35,153,512 53.98
6 Month 1,800,948 74,091,009 41.14

Nectar Lifesciences Result Highlights

Nectar Lifesciences Synopsis

NSE-Medical-Generic Drugs

Nectar Lifesciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1523.67 Cr. and Equity Capital is Rs. 22.43 Cr. for the Year ended 31/03/2023. Nectar Lifesciences Ltd. is a Public Limited Listed company incorporated on 27/06/1995 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L24232PB1995PLC016664 and registration number is 016664.
Market Cap 731
Sales 1,633
Shares in Float 12.56
No of funds 13
Yield 0.22
Book Value 0.69
U/D Vol ratio 2.5
LTDebt / Equity 21
Alpha 0.16
Beta 1.22

Nectar Lifesciences

Owner NameMar-24Dec-23Sep-23Jun-23
Promoters 55.8%55.8%55.8%55.8%
Mutual Funds
Foreign Portfolio Investors 2.39%1.53%1.43%1.41%
Individual Investors 23.32%24.34%24.46%24.61%
Others 18.49%18.33%18.31%18.18%

Nectar Lifesciences Management

Name Designation
Mr. Sanjiv Goyal Chairman & Managing Director
Dr. Indu Pal Kaur Independent Director
Mr. Ajay Swaroop Independent Director
Dr. Rupinder Tewari Independent Director
Dr. Kuldip Kumar Bhasin Independent Director
Mr. Puneet Sud Whole Time Director
Ms. Meena Verma Nominee Director

Nectar Lifesciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Nectar Lifesciences Corporate Action

Date Purpose Remarks
2024-02-14 Quarterly Results
2023-11-10 Quarterly Results
2023-08-14 Quarterly Results
2023-05-26 Audited Results & A.G.M.
2023-02-14 Quarterly Results

Nectar Lifesciences MF Shareholding

Name Amount(cr)

Nectar Lifesciences FAQs

What is Share Price of Nectar Lifesciences ?

Nectar Lifesciences share price is ₹32 As on 16 April, 2024 | 00:26

What is the Market Cap of Nectar Lifesciences ?

The Market Cap of Nectar Lifesciences is ₹731.1 Cr As on 16 April, 2024 | 00:26

What is the P/E ratio of Nectar Lifesciences ?

The P/E ratio of Nectar Lifesciences is 90.5 As on 16 April, 2024 | 00:26

What is the PB ratio of Nectar Lifesciences ?

The PB ratio of Nectar Lifesciences is 0.7 As on 16 April, 2024 | 00:26

Q2FY23